NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
In recent years much has happened to justify an examination of biological research in light of national security concerns. The destructive application of biotechnology research includes activities such as spreading common pathogens or transforming them into even more lethal forms. Policymakers and the scientific community at large must put forth a vigorous and immediate response to this challenge. This new book by the National Research Council recommends that the government expand existing regulations and rely on self-governance by scientists rather than adopt intrusive new policies. One key recommendation of the report is that the government should not attempt to regulate scientific publishing but should trust scientists and journals to screen their papers for security risks, a task some journals have already taken up. With biological information and tools widely distributed, regulating only U.S. researchers would have little effect. A new International Forum on Biosecurity should encourage the adoption of similar measures around the world. Seven types of risky studies would require approval by the Institutional Biosafety Committees that already oversee recombinant DNA research at some 400 U.S. institutions. These “experiments of concern” include making an infectious agent more lethal and rendering vaccines powerless.
Contents
- THE NATIONAL ACADEMIES
- COMMITTEE ON RESEARCH STANDARDS AND PRACTICES TO PREVENT THE DESTRUCTIVE APPLICATION OF BIOTECHNOLOGY
- Preface
- Acknowledgments
- Executive Summary
- 1. Introduction
- THE LIFE SCIENCES TODAY
- THE DUAL USE DILEMMA
- A BRIEF HISTORY OF MODERN BIOLOGICAL WARFARE
- U.S. POLICY AND THE CREATION OF THE BIOLOGICAL AND TOXIN WEAPONS CONVENTION
- THE NEW THREAT
- RECENT EXAMPLES OF “CONTENTIOUS RESEARCH” IN THE LIFE SCIENCES
- THE RESPONSE OF THE LIFE SCIENCES COMMUNITY TO PREVIOUS CHALLENGES
- COMMITTEE CHARGE AND PROCESS
- ANNEX: BIOLOGICAL WARFARE IN HISTORY
- 2. The Evolving Regulatory Environment for Life Sciences Research in the 21st Century
- INTRODUCTION
- THE U.S. REGULATORY ENVIRONMENT
- FRAMEWORK FOR IMPLEMENTATION OF THE NIH GUIDELINES FOR RDNA RESEARCH
- TYPES OF EXPERIMENTS THAT REQUIRE IBC, RAC, AND NIH DIRECTOR REVIEW
- PHYSICAL AND BIOLOGICAL CONTAINMENT STRATEGIES FOR NIH-FUNDED rDNA RESEARCH ACTIVITIES
- COMPLIANCE WITH AND ENFORCEMENT OF THE NIH GUIDELINES
- REGULATION OF MICROBIAL AGENTS (LISTED AGENTS AND TOXINS)
- POSSESSION OF SELECT AGENTS
- IMPORTATION AND INTERSTATE SHIPMENT OF ETIOLOGIC AGENTS
- OVERSIGHT OF FOREIGN NATIONALS
- PROFESSIONAL EDUCATION AND RESPONSIBILITIES OF LIFE SCIENTISTS
- THE INTERNATIONAL SITUATION
- CONCLUSIONS
- ANNEX
- 3. Information Restriction and Control Regimes
- 4. Conclusions and Recommendations
- Appendix A ACRONYMS
- Appendix B Biographical Sketches of Committee Members
- Appendix C Committee Meetings
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the Committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
The development of this report was supported by the Alfred P. Sloan Foundation and the Nuclear Threat Initiative. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project.
- NLM CatalogRelated NLM Catalog Entries
- Establishing a national biosafety and biosecurity agency for the United States.[Front Bioeng Biotechnol. 2024]Establishing a national biosafety and biosecurity agency for the United States.Gillum DR, Moritz R, Koblentz GD. Front Bioeng Biotechnol. 2024; 12:1474120. Epub 2024 Oct 17.
- Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.[Front Bioeng Biotechnol. 2022]Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.Xue Y, Shang L. Front Bioeng Biotechnol. 2022; 10:939295. Epub 2022 Jul 4.
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.[Cochrane Database Syst Rev. 2022]Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, et al. Cochrane Database Syst Rev. 2022 Feb 1; 2(2022). Epub 2022 Feb 1.
- Improving U.S. Biosafety and Biosecurity: Revisiting Recommendations from the Federal Experts Security Advisory Panel and the Fast Track Action Committee on Select Agent Regulations.[Appl Biosaf. 2023]Improving U.S. Biosafety and Biosecurity: Revisiting Recommendations from the Federal Experts Security Advisory Panel and the Fast Track Action Committee on Select Agent Regulations.Haines CA, Gronvall GK. Appl Biosaf. 2023 Mar 1; 28(1):43-54. Epub 2023 Mar 6.
- Review Building Infectious Disease Research Programs to Promote Security and Enhance Collaborations with Countries of the Former Soviet Union.[Front Public Health. 2015]Review Building Infectious Disease Research Programs to Promote Security and Enhance Collaborations with Countries of the Former Soviet Union.Bartholomew JC, Pearson AD, Stenseth NC, LeDuc JW, Hirschberg DL, Colwell RR. Front Public Health. 2015; 3:271. Epub 2015 Nov 26.
- Biotechnology Research in an Age of TerrorismBiotechnology Research in an Age of Terrorism
Your browsing activity is empty.
Activity recording is turned off.
See more...